Related Experiment Video
Updated: Aug 5, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Macrophage FOLR2 drives liver fibrosis via intercellular engagement of TGFβRII
Man-Man Yuan1, Bing-Feng Zheng1, Jing-Lin Wang2
1State Key Laboratory of Pharmaceutical Biotechnology, Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, School of Life Sciences, Nanjing University, Nanjing, 210093, China.
Abstract:
Hepatic stellate cells (HSCs) and macrophages are key regulators of liver fibrosis, yet their direct communication during fibrogenesis remains incompletely characterized. We showed that genetic deletion of folate receptor beta (Folr2) significantly attenuated experimental liver fibrosis in mice. In both human and murine fibrotic livers, FOLR2+ macrophages are frequently juxtaposed with activated HSCs. Functionally, FOLR2 expressed by reparative, but not M1 or scar-associated, macrophages promotes HSC activation in a contact-dependent manner. Mechanistically, FOLR2 binds to transforming growth factor beta receptor II (TGFβRII) on HSCs, sustaining transforming growth factor beta 1 (TGF-β1) signaling and driving fibrogenesis. Finally, the natural compound fraxinellone targets FOLR2, disrupts its interaction with TGFβRII, and attenuates HSC activation and liver fibrosis. These findings identify the FOLR2-TGFβRII intercellular interaction as a critical mediator of macrophage-HSC crosstalk and highlight its disruption as a promising therapeutic strategy against liver fibrosis.
Insights
Targeting folate receptor beta (Folr2) on macrophages disrupts communication with hepatic stellate cells (HSCs), reducing liver fibrosis. Fraxinellone, a natural compound, blocks this interaction, offering a potential therapy.
Area of Science:
- Cell Biology
- Immunology
- Hepatology
Background:
- Liver fibrosis involves hepatic stellate cells (HSCs) and macrophages.
- Direct communication between these cells during fibrosis is not fully understood.
Purpose of the Study:
- To investigate the role of folate receptor beta (Folr2) in macrophage-HSC crosstalk during liver fibrosis.
- To identify therapeutic targets for liver fibrosis.
Main Methods:
- Genetic deletion of Folr2 in mice.
- Immunohistochemistry on human and murine fibrotic liver samples.
- Co-culture assays to assess HSC activation.
- Molecular analysis of TGF-β signaling.
- Treatment with the natural compound fraxinellone.
Main Results:
- Genetic deletion of Folr2 attenuated experimental liver fibrosis.
- FOLR2-expressing macrophages were found near activated HSCs in fibrotic livers.
- FOLR2 on reparative macrophages promoted HSC activation via contact-dependent mechanisms.
- FOLR2 binds to TGFβRII on HSCs, sustaining TGF-β1 signaling.
- Fraxinellone disrupted the FOLR2-TGFβRII interaction, reducing HSC activation and fibrosis.
Conclusions:
- The FOLR2-TGFβRII interaction is crucial for macrophage-HSC crosstalk in liver fibrosis.
- Targeting this interaction, for example with fraxinellone, is a potential therapeutic strategy for liver fibrosis.
More Related Videos
Related Concept Videos
Cirrhosis II: Pathophysiology
Chronic Inflammation: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
TGF - β Signaling Pathway
Cirrhosis I: Introduction
Inflammation

